Rocket Pharmaceuticals, Inc. (RCKT)
2.655
+0.06
(+2.12%)
USD |
NASDAQ |
Jun 11, 14:49
Rocket Pharmaceuticals Market Cap : 289.72M for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 283.72M |
| June 09, 2026 | 289.18M |
| June 08, 2026 | 294.63M |
| June 05, 2026 | 300.09M |
| June 04, 2026 | 318.64M |
| June 03, 2026 | 318.64M |
| June 02, 2026 | 315.37M |
| June 01, 2026 | 329.55M |
| May 29, 2026 | 335.01M |
| May 28, 2026 | 329.55M |
| May 27, 2026 | 326.49M |
| May 26, 2026 | 327.58M |
| May 22, 2026 | 323.21M |
| May 21, 2026 | 339.59M |
| May 20, 2026 | 324.30M |
| May 19, 2026 | 318.84M |
| May 18, 2026 | 335.22M |
| May 15, 2026 | 354.88M |
| May 14, 2026 | 371.26M |
| May 13, 2026 | 393.10M |
| May 12, 2026 | 397.46M |
| May 11, 2026 | 392.00M |
| May 08, 2026 | 396.37M |
| May 07, 2026 | 400.74M |
| May 06, 2026 | 421.49M |
| Date | Value |
|---|---|
| May 05, 2026 | 386.54M |
| May 04, 2026 | 394.19M |
| May 01, 2026 | 386.51M |
| April 30, 2026 | 377.82M |
| April 29, 2026 | 377.82M |
| April 28, 2026 | 372.39M |
| April 27, 2026 | 378.91M |
| April 24, 2026 | 382.16M |
| April 23, 2026 | 399.53M |
| April 22, 2026 | 412.56M |
| April 21, 2026 | 397.36M |
| April 20, 2026 | 419.08M |
| April 17, 2026 | 424.51M |
| April 16, 2026 | 423.42M |
| April 15, 2026 | 421.25M |
| April 14, 2026 | 395.19M |
| April 13, 2026 | 395.19M |
| April 10, 2026 | 378.91M |
| April 09, 2026 | 390.85M |
| April 08, 2026 | 390.85M |
| April 07, 2026 | 377.82M |
| April 06, 2026 | 375.65M |
| April 02, 2026 | 385.42M |
| April 01, 2026 | 393.02M |
| March 31, 2026 | 388.68M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Replimune Group, Inc. | 704.34M |
| ProKidney Corp. | 234.27M |
| Arrowhead Pharmaceuticals, Inc. | 10.50B |
| Oncolytics Biotech, Inc. | 92.94M |
| Sangamo Therapeutics, Inc. | 61.73M |
Market Cap Related Metrics
| Price to Book Value | 1.217 |
| Price | 2.655 |
| Earnings Yield | -70.69% |